康敏元格氏乳酸杆菌抗过敏对于气喘合并过敏性鼻炎儿童的影响（Effect of anti anaphylaxis by Kang Minyuans Lactobacillus on children with asthma and allergic rhinitis）.docVIP

康敏元格氏乳酸杆菌抗过敏对于气喘合并过敏性鼻炎儿童的影响（Effect of anti anaphylaxis by Kang Minyuans Lactobacillus on children with asthma and allergic rhinitis） Effect of anti hypersensitivity of Kang Minyuan low Lactobacillus on children with asthma and allergic rhinitis Randomized, Placebo-Controlled, Trial, of, Lactobacillus, on, Asthmatic, Children,, With, Allergic, Rhinits. Source: Pediatric Pulmonology; 2010 Abstract: A review of past literature indicates that probiotics may be effective in the treatment or improvement of atopic dermatitis in infants, but the role of probiotics in allergic respiratory diseases remains controversial. In order to confirm its efficacy, this experiment also suffer from asthma and allergic rhinitis children as the object, L. gasseri A5 probiotic supplement every day for eight weeks, to investigate whether can improve clinical symptoms and regulate the immune function. A randomized double blind trial was conducted on 6-12 year old school children with asthma and allergic rhinitis. The two groups were supplemented with probiotics, L., gasseri, A5 (49) and placebo (51 persons), with a trial duration of two months. During the trial, the physician assessed lung function, as well as the improvement in asthma and allergic rhinitis, and seriously increased the use of the drug during the trial. The daily and early records of participants were measured daily: peak expiratory flow, asthma, and allergic rhinitis. In the evaluation of immunity, the total amount of IgE before and after the consumption of probiotics and the secretion of various cytokines by PBMC cells were analyzed. The test results show that compared with the placebo group, probiotics patients whose lung function and peak expiratory flow (PEFR) has significantly improved, as well as asthma and allergic rhinitis and other clinical symptoms have reduced the situation. Conclusions: supplementation of the Kang Minyuan probiotic Lactobacillus L. gasseri PM-A0005 has a clinically improved effect in children wit